Hinge Health, Inc.
HNGE
NYSE·Healthcare·Medical - Healthcare Information Services·Mkt cap $6.8B
$87.35
▼ -5.92%
P/E
64.87
Mkt Cap
$6.8B
52-Wk Range
$30.08–$95.57
52-Week Range
$30.08 - $95.57
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 56.9% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Proprietary AI-powered clinical platform and patient engagement technology
- Established relationships with major employers and health plans
- Comprehensive clinical team combining software engineering with healthcare expertise
- Strong brand recognition in the musculoskeletal care digital health space
Bear Case
2 risks
- Average volatility.
- Growth premium of 1.8x vs Healthcare IT & Services peers. Elevated but may be justified by growth trajectory.
Growth
Moderate growth ahead
Increasing employer demand for cost-effective musculoskeletal care solutions
Value
Growth premium of 1.8x vs Healthcare IT & Services peers. Elevated but may be justified by growth trajectory.
Momentum
Hot
+55.4% over 3m
Quality
Excellent
High-growth business (50% revenue growth, 85% gross margin). Profitable with strong growth momentum.
Dividend
None
No dividend
Smart-money signal
Who's buying HNGE right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 3, 2026
AUG 4, 2026
Reported EPS of $0.59 vs $0.62 consensus (-4.1% surprise). Revenue of $212.8M vs $201.5M expected (+5.6%).
EPS surprise · last 4Q
0 of 1 beats
Estimate
Actual
Q3 26
-4.1%
Revenue trend · last 8Q
—
—
+50%
+55%
+53%
+46%
+47%
+53%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$100.6M
$117.3M
$123.8M
$139.1M
$154.2M
$170.7M
$182.3M
$212.8M
Margins · last 8Q
Gross
86.4%
Operating
19.0%
Profit
20.5%
Wall Street consensus
13 analysts · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
—
Latest: Evercore · Aug 5, 2026
vs Industry
How HNGE stacks vs Medical - Healthcare Information Services
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related